Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2888 (LINC02888)

Target
LINC02888
Molecular classification
Long non-coding RNA, Long intergenic non-coding RNA (lincRNA), Non-protein-coding RNA
01

Overview

Long intergenic non-protein coding RNA 2888 (LINC02888, also known as KCCAT333 or renal clear cell carcinoma-associated transcript 333) is a long intergenic non-coding RNA (lincRNA), defined as an RNA transcript longer than 200 nucleotides which does not overlap with protein-coding genes and is not translated into protein[1][3]. Its alternative name suggests an association with clear cell renal cell carcinoma, a common type of kidney cancer, but the specific function and mechanism of LINC02888 in this context remain uncharacterized in available sources. LincRNAs are known to regulate gene expression at various levels (epigenetic, transcriptional, post-transcriptional) and can act locally (cis) or at distant sites (trans)[1][3]. Some lincRNAs have been implicated in oncogenesis and as potential diagnostic or prognostic biomarkers in cancer, but it is unclear whether LINC02888 has a validated driver or therapeutic role[3]. The exact biological role, interacting molecules, and druggability of this lincRNA are not established in the current literature.

Other names
KCCAT333renal clear cell carcinoma-associated transcript 333
02

Biological functions

Gene regulation (general class)Epigenetic regulation (inferred for lncRNAs/lincRNAs)Other
03

Disease associations

Cancer (by association—see explanation)Other
04

Biomarkers

Potential biomarker for clear cell renal cell carcinoma (inferred from its name and alias; not clearly validated in search results)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2888 (LINC02888).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2888 (LINC02888).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call